| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.05B | 11.36B | 8.70B | 6.89B | 6.05B | 5.15B |
| Gross Profit | 1.14B | 1.17B | 816.42M | 633.36M | 572.50M | 505.24M |
| EBITDA | 803.51M | 773.16M | 3.22B | 405.05M | 300.44M | 224.29M |
| Net Income | 308.36M | 269.19M | 2.75B | 77.90M | 33.52M | 52.38M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 9.06B | 7.91B | 5.60B | 4.72B | 5.07B |
| Cash, Cash Equivalents and Short-Term Investments | 12.89M | 43.57M | 2.57M | 1.93M | 3.91M | 7.52M |
| Total Debt | 0.00 | 3.04B | 2.98B | 2.93B | 2.72B | 2.66B |
| Total Liabilities | -3.05B | 6.02B | 5.38B | 3.47B | 3.08B | 3.47B |
| Stockholders Equity | 3.05B | 3.04B | 2.53B | 2.14B | 1.63B | 1.60B |
Cash Flow | ||||||
| Free Cash Flow | -9.26M | -262.17M | 2.49B | -359.61M | 197.00M | -271.98M |
| Operating Cash Flow | -7.79M | -248.82M | 2.50B | -357.49M | 198.56M | -268.63M |
| Investing Cash Flow | -42.50M | -41.32M | 156.84M | -58.36M | -8.07M | -51.21M |
| Financing Cash Flow | 50.17M | 300.46M | -64.84M | 413.51M | -194.09M | 312.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | ₹10.17B | 21.27 | ― | ― | 23.11% | 1930.97% | |
63 Neutral | ₹7.67B | 12.27 | ― | 2.91% | -15.70% | -4.19% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | ₹6.30B | 179.87 | ― | ― | 24.66% | 59.09% | |
54 Neutral | ₹4.97B | 14.61 | ― | 0.43% | 11.46% | -0.46% | |
51 Neutral | ₹5.07B | 14.37 | ― | ― | 29.26% | 46.09% | |
48 Neutral | ₹7.10B | 89.10 | ― | 6.20% | 86.75% | ― |
Sarveshwar Foods Limited has announced that 10.2 crore warrants, issued on a preferential basis in July 2024 and entitling holders to subscribe to an equivalent number of equity shares within 18 months, have lapsed after the allottees failed to exercise their conversion option by the 24 January 2026 deadline. As a result, the company has forfeited the upfront payment of approximately Rs 23.78 crore—representing 25% of the issue price—received from these warrant holders, including several institutional investors, which halts the expected equity dilution while providing a non-refundable capital inflow that modestly strengthens the company’s balance sheet and alters the anticipated shareholder base composition.
Sarveshwar Foods Limited has approved the allotment of 37,50,000 equity shares of face value Re 1 each at an issue price of Rs 9.70 per share, following the conversion of an equivalent number of warrants issued on a preferential basis. The conversion, approved by the board through a resolution passed by circulation on 24 January 2026, brought in Rs 2.73 crore as 75% of the issue price payable on conversion, and increases the company’s paid-up equity share capital to Rs 123.27 crore, with the newly issued shares ranking pari passu with existing equity. This step forms part of a larger warrant issue previously approved in July 2024 and underscores the company’s continued use of preferential allotments to strengthen its equity base and fund its strategic and operational requirements, with implications for shareholding dilution and capital structure for current investors.
Sarveshwar Foods Limited announced that there is no deviation or variation in the utilization of funds raised through its recent rights issue, as confirmed by the company’s audit committee. This assurance of proper fund utilization underscores the company’s commitment to transparency and adherence to regulatory requirements, potentially strengthening stakeholder confidence and supporting its strategic financial management.
Sarveshwar Foods Limited has released a Monitoring Agency Report for the quarter ending September 30, 2025, in connection with its recent rights issue of shares. The report, reviewed by Infomerics Valuation & Rating Limited and approved by the company’s Audit Committee and Board of Directors, is part of the company’s compliance with regulatory requirements. This development is significant for stakeholders as it reflects the company’s commitment to transparency and regulatory adherence, potentially impacting its market positioning and investor confidence.